Christopher N Hurt

7PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer diagnosisRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 27, 2025
Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancer.

Mererid Evans, Chris Hurt, Rhian Rhys

|Sep 30, 2025
ColoCap: determining the diagnostic accuracy of colon capsule endoscopy compared with standard colonoscopy in patients at risk of colorectal disease - a study protocol.

Hussain Ibrahim, Monica Haritakis, Lisa Ballantine

|May 13, 2022
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations.

Sarah R Brown, Samantha Hinsley, Emma Hall

|Jun 30, 2021
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma.

Michelle R Goulart, Jennifer Watt, Imran Siddiqui

|May 27, 2021
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT.

Douglas Adamson, Jane Blazeby, Catharine Porter

|Oct 26, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.

Frances Willenbrock, Catrin M Cox, Eileen E Parkes

Pageof 2

Frequent Collaborators

2 joint publications

Lisette Sheena Nixon

1 joint publications

Michelle R Goulart

1 joint publications

Ahmet Imrali

1 joint publications

Christine Hughes